Lexicon Pharmaceuticals, Inc. (LXRX)
-NasdaqGS 2.17
0.09(3.98%) 4:00PM EDT
| Prev Close: | 2.26 |
|---|
| Open: | 2.25 |
|---|
| Bid: | 2.01 x 200 |
|---|
| Ask: | 2.30 x 200 |
|---|
| 1y Target Est: | 3.00 |
|---|
| Beta: | 2.55 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 2.17 - 2.27 |
|---|
| 52wk Range: | 1.55 - 3.28 |
|---|
| Volume: | 420,323 |
|---|
| Avg Vol (3m): | 853,128 |
|---|
| Market Cap: | 1.11B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.21 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and OperationsPR Newswire(Tue, Jun 18)
- Lexicon Pharmaceuticals' Management Presents at 38th Annual dbAccess Health Care Conference (Transcript)at Seeking Alpha(Wed, Jun 12)
- Lexicon dips as analyst questions diabetes drugAP(Tue, Jun 11)
- Stock Downgrades: Dark Day for Lululemonat Minyanville(Tue, Jun 11)
- Lexicon To Present At The Goldman Sachs Global Healthcare ConferencePR Newswire(Fri, Jun 7)
- Which of These Billion-Dollar Biotechs Is a Buy?at Motley Fool(Sat, Jun 1)
- Lexicon To Present At The Jefferies Global Healthcare ConferencePR Newswire(Fri, May 31)
- Lexicon Pharmaceuticals' CEO Presents at 38th Annual dbAccess Health Care Conference (Transcript)at Seeking Alpha(Wed, May 29)
- Lexicon To Present At The Deutsche Bank dbAccess Healthcare ConferencePR Newswire(Tue, May 28)
- LEXICON PHARMACEUTICALS, INC./DE FinancialsEDGAR Online Financials(Fri, May 17)
- Lexicon's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)at Seeking Alpha(Thu, May 16)
- Lexicon To Present At The Bank of America Merrill Lynch Healthcare ConferencePR Newswire(Mon, May 13)
- Lexicon Pharmaceuticals Earnings Call Nuggets: Partnership Talks Update and Carcinoid Enrollmentat Wall St. Cheat Sheet(Sun, May 12)
- Lexicon Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 10)
- Q1 2013 Lexicon Pharmaceuticals Inc. Earnings Release - Before Market OpenCCBN(Fri, May 10)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1,009.08 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.19 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.05 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 0.50 |
|---|
Business Summary
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for human disease. Its portfolio of orally-delivered small molecule compounds in clinical development include LX4211 that has comple...
View More